The research report provides an in-depth evaluation of the Global Pharmacogenomics Market and helps the market participants intensify their footprints in the industry. The report gives a detailed analysis concentrated on the critical market dynamics such as drivers, restraints, trends, and growth opportunities to assist businesses to prepare for any challenges they might encounter in the forecast period. It also offers a regional analysis of the global Pharmacogenomics market to explore possible growth prospects available in different parts of the world. The competitive landscape is broadly evaluated alongside the company profiles of key players engaged in the global Pharmacogenomics market. The report offers a detailed statistical evaluation and accurate market data, viz., market share, CAGR, gross margin, revenue, consumption, production, and sales. The global Pharmacogenomics Market is expected to reach USD 11.97 Billion by 2027, according to a new report by Emergen Research.
You Can
Download Free Sample PDF Copy of Pharmacogenomics Market at https://www.emergenresearch.com/request-sample/88
Key Highlights
From The Report
The software under the product and services segment is
expected to have the largest market share. This is attributed to the widespread
application of genomic data to effectively influence healthcare outcomes. The
testing methods are improved, and the public and health care professionals are
educated about the potential benefits owing to technological advancements.
The pharmacogenomics by application includes Oncology as one
of the prospects which are expected to fuel the market growth. Pharmacogenomics
is expected to help guide healthcare professionals to personalize treatment for
cancer patients, which will contribute significantly to the market.
Research organizations held a significant share in 2019,
owing to its contribution to the research field. It is a relatively new field
that combines pharmacology and genomics to develop effective, safe medications
and doses that will be tailored to a person's genetic makeup.
The major driving factors for the growth of this market in
the North American region is the rising demand for personalized medicines, high
medical reimbursement facilities, and technological advancement.
Key participants include Abbott Laboratories, Admera Health,
LLC, Agena Biosciences, Inc., Cancer Genetics, Inc., Dynamic DNA Laboratories,
F. Hoffmann-La Roche Ltd, geneOmbio Technologies Pvt Ltd., Genomic Health,
Inc., Illumina, Inc., and Laboratory Corporation of America Holdings, among
others.
Product
and Services Outlook (Revenue, USD Billion; 2017-2027)
Products
Kits
Assays and Reagents
Instruments
Software
Services
Genotyping
SNP Identification
Pharmacogenetic Testing
Other Services
Technology
Outlook (Revenue, USD Billion; 2017-2027)
Polymerase Chain Reaction (PCR)
Real-Time PCR
qPCR
Digital PCR
DNA Sequencing/Next Generation Sequencing (NGS)
Nucleic Acid Amplification Tests (NAATs)
Mass Spectrometry
Gel Electrophoresis
Hybridization
Fluorescence In Situ Hybridization (FISH)
Chromogenic In Situ Hybridization (CISH)
Others
Microarray
Others
Application
Outlook (Revenue, USD Billion; 2017-2027)
Oncology
Infectious Diseases
Neurology/Psychiatry
Cardiovascular
Others
End-Use
Outlook (Revenue, USD Billion; 2017-2027)
Research Organization
Pharmaceutical Companies
Diagnostic Centers
Others
Regional
scope: North America; Europe; Asia Pacific; Central & South
America; MEA
Read
more@ https://www.emergenresearch.com/industry-report/pharmacogenomics-market
Table
of Content
Chapter 1. Methodology & Sources
1.1. Market
Definition
1.2. Research
Scope
1.3. Methodology
1.4. Research
Sources
1.4.1.
Primary
1.4.2.
Secondary
1.4.3. Paid
Sources
1.5. Market
Estimation Technique
Chapter 2. Executive Summary
2.1. Summary
Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. Pharmacogenomics Market Segmentation & Impact
Analysis
4.1. Pharmacogenomics
Market Material Segmentation Analysis
4.2. Industrial
Outlook
4.2.1.
Market indicators analysis
4.2.2.
Market drivers analysis
4.2.2.1. Growing demand for growing medicinal application
4.2.2.2. Rising legalization of Pharmacogenomics
4.2.2.3. Technological advancement in product invention
4.2.3.
Market restraints analysis
4.2.3.1. The complex regulatory framework for the usage of Pharmacogenomics
4.3. Technological
Insights
4.4. Regulatory
Framework
4.5. Porter’s Five
Forces Analysis
4.6. Competitive
Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19
Impact Analysis
Continued…
No comments:
Post a Comment